1. Cogal, Andrea G, Arroyo, Jennifer, Shah, Ronak Jagdeep, Lieske, John C, Harris, Peter C. 2021. Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease. In Kidney international reports, 6, 2862-2884. doi:10.1016/j.ekir.2021.08.033. https://pubmed.ncbi.nlm.nih.gov/34805638/
2. Takayama, T, Takaoka, N, Nagata, M, Sugimura, H, Ozono, S. 2013. Ethnic differences in GRHPR mutations in patients with primary hyperoxaluria type 2. In Clinical genetics, 86, 342-8. doi:10.1111/cge.12292. https://pubmed.ncbi.nlm.nih.gov/24116921/
3. Yang, Shuangshuang, Liu, Yixian, Zhang, Bushi, Zhao, Qianwei, Zhang, Jintao. 2024. GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway. In Cancer biotherapy & radiopharmaceuticals, 39, 733-744. doi:10.1089/cbr.2023.0018. https://pubmed.ncbi.nlm.nih.gov/38934120/
4. Chatterjee, Arindam, Sarkar, Kunal, Bank, Sarbashri, Chattopadhyay, Debprasad, Das, Madhusudan. 2022. Homozygous GRHPR C.494G>A mutation is deleterious that causes early onset of nephrolithiasis in West Bengal, India. In Frontiers in molecular biosciences, 9, 1049620. doi:10.3389/fmolb.2022.1049620. https://pubmed.ncbi.nlm.nih.gov/36619171/
5. Levin-Iaina, Nomy, Dinour, Dganit, Romero, Lina, Cramer, Scott D, Holtzman, Eli J. 2009. Late diagnosis of primary hyperoxaluria type 2 in the adult: effect of a novel mutation in GRHPR gene on enzymatic activity and molecular modeling. In The Journal of urology, 181, 2146-51. doi:10.1016/j.juro.2009.01.045. https://pubmed.ncbi.nlm.nih.gov/19296982/
智鼠故事 
